300511 雪榕生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-5.205-49.501-11.405-16.833-15.834
总资产报酬率 ROA (%)-1.672-14.594-4.336-6.831-6.572
投入资产回报率 ROIC (%)-2.070-17.661-5.035-7.788-7.536

边际利润分析
销售毛利率 (%)7.4123.6058.38410.7045.263
营业利润率 (%)-4.044-28.385-7.422-16.166-15.842
息税前利润/营业总收入 (%)-0.816-24.115-4.215-12.923-12.557
净利润/营业总收入 (%)-4.242-28.505-7.498-16.985-16.077

收益指标分析
经营活动净收益/利润总额(%)142.06433.50371.215-1.44645.833
价值变动净收益/利润总额(%)-1.8270.1051.381-2.331-0.300
营业外收支净额/利润总额(%)3.3650.4200.8901.4262.776

偿债能力分析
流动比率 (X)0.4030.2800.3630.9190.545
速动比率 (X)0.1270.1130.1530.5770.306
资产负债率 (%)62.54878.64068.87660.07361.878
带息债务/全部投入资本 (%)45.28966.34356.62647.23451.569
股东权益/带息债务 (%)112.12844.86271.595101.52286.616
股东权益/负债合计 (%)64.67730.96549.04271.26462.260
利息保障倍数 (X)-0.242-5.493-1.287-3.717-3.359

营运能力分析
应收账款周转天数 (天)6.9005.4004.3864.4904.594
存货周转天数 (天)76.90166.33567.87271.87370.621